Wang, Zhiguo <br/><br/>
Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy.  [electronic resource] 

 -  Life sciences  Sep 2019 
 - 116622 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2019.116622  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzhydryl Compounds--metabolism<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Disease Models, Animal<br/>Drug Therapy, Combination--methods<br/>Glucose--metabolism<br/>Glucosides--metabolism<br/>Lipid Metabolism--drug effects<br/>Male<br/>Metformin--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Sodium-Glucose Transporter 2 Inhibitors--metabolism<br/>Treatment Outcome